Filing Flows › Opus Genetics (IRD) › Q1 2026 › vs Q4 2025
Opus Genetics (IRD) Q1 2026 vs Q4 2025 (quarter over quarter)
Opus Genetics's revenue fell $1.7M (-44%) from $3.9M in Q4 2025 to $2.2M in Q1 2026.
Opus Genetics, Q1 2026: revenue $2.2M (-51% year over year), operating margin -665.9%, net loss $65.5M, operating cash flow −$12.7M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.2M | $3.9M | −$1.7M | -44% |
| Net loss | $65.5M | $16.5M | $49.0M | +297% |
| Costs & expenses | $67.7M | $20.4M | $47.3M | +232% |
| Operating costs | $16.5M | $15.3M | $1.2M | +8% |
| Interest & other, net | $51.2M | $5.1M | $46.1M | +909% |
| Research & development | $10.6M | $10.4M | $149K | +1% |
| General & admin | $5.9M | $4.9M | $1.1M | +22% |
| Operating cash sources | $65.5M | $16.5M | $49.0M | +297% |
| Depreciation | $13K | $13K | $0 | 0% |
| Share-based compensation | $1.5M | $774K | $690K | +89% |
| Working capital & other | $51.3M | $5.9M | $45.4M | +770% |
| Cash used in operations | $12.7M | $9.8M | $2.9M | +29% |
| Net loss absorbed | $65.5M | $16.5M | $49.0M | +297% |
Questions
How much did Opus Genetics's revenue grow quarter over quarter in Q1 2026?
Opus Genetics's revenue fell $1.7M (-44%) from $3.9M in Q4 2025 to $2.2M in Q1 2026.